Twitter Linkedin Envelope
REQUEST A CALL

Therapeutic Expertise

home-hero-underline

Enhancing the diversity of clinical trial populations as experts in recruitment and retention

Therapeutic Experience

Total Diversity Expertise Graph
Total Diversity Expertise Graph

100% Enrollment Targets

Leading with a combined 50 years’ experience, the Total Diversity diversity and inclusion team utilizes a multifaceted approach to reach diverse populations and encourage participation in clinical trials. Recognized as subject-matter experts in the area of patient recruitment and retention with an established track record of 100% enrollment for every study within the targeted timeline, our expertise will be your reliable resource for enhancing the diversity of clinical trial populations for your study.

The same team was instrumental in developing one of the first global patient recruitment and retention companies within the industry. For more than a decade, our recruitment campaigns were designed and executed to reach and educate diverse populations across all therapeutic areas. Total Diversity has successfully implemented innovative virtual services to create new networks with populations around the country previously unknown to clinical research. Our growing database of proven regional recruitment strategists and our expertise of creating targeted population marketing initiatives, has maintained the TOTAL Edge as a catalyst to complete your study! The future of efficient patient care depends on enrolling diverse populations to maximize the generalizability of trial results, which will better reflect the true diversity of the patients who will be using the drug once it is approved.

Diversity Enrollment

Leading with a combined 50 years’ experience, the Total Diversity executive team utilizes a multifaceted approach to network diverse populations and encourage their participation in clinical trials.

LEARN MORE
REQUEST A CALL

Diana L. Foster, Ph.D

CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management

Diana L. Foster, Ph.D., is the CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management, a full-service Diversity Organization whose mission is to enhance diversity and inclusion in clinical research trials. Foster has served as the Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS) since 2016. She also held a position as the Vice President of Strategy and Development for SCRS originating programs such as the Global Impact Partner Programs and many other industry supported initiatives.

Foster is a thought-leader and sought-after expert in diversity and clinical site best practices. She is the author of the Diversity Site Assessment Tool and has published numerous research papers on the topic. Over the past two decades, she has addressed audiences across the world, published multiple papers and articles, and written five authoritative industry books including Global Issues in Patient Recruitment and Retention.

Jerome Adams, M.D.

Chairman of the Board for TOTAL Diversity Clinical Trial Management

Dr. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials.

As the Chairman of the Board for TOTAL Diversity, Dr. Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.